Moderna’s cancer vaccine hits its targets, but an embargo breach rattles investors and the stock tumbles
Questions of a ‘sell-the-news reaction.’ The experimental treatment helped prevent the return of cancer or death in melanoma patients by 42% after two years
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.marketwatch.com — the content belongs to MarketWatch.
